HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) [Phase 3]
Phase 3 trial ANRS 161 L-VIR evaluating management of participants with low-level persistent HIV-1 viremia; the study status is TERMINATED.
-
CLINICAL_TRIALS research · 2015-10-12Clinical Trial Update: Evaluation of an Innovative Tuberculosis Diagnostic Test
An update on an evaluation study of an innovative tuberculosis diagnostic test, sponsored by ANRS and Emerging Infectious Diseases; the tria…
-
CLINICAL_TRIALS research · 2015-10-12Clinical Trial Update: Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project. [NA]
This document provides an update on a demonstrative project implementing pre-exposure prophylaxis (PrEP) for HIV prevention.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection [Phase 1]
Phase 1 trial evaluating erlotinib hydrochloride for HIV-infected patients with metastatic or unresectable non-small cell lung cancer was te…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Clinical trial update on a study developing a urine fructose identification method to detect HIV infection. The trial has completed and resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-10-02Clinical Trial Update: HIV-1 Vaccine Test in Uninfected Adult Volunteers [Phase 1]
A Phase 1 HIV-1 vaccine trial in uninfected adult volunteers was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease [Phase 4]
This Phase 4 study evaluated how much dolutegravir is removed by hemodialysis in HIV-infected patients with end-stage renal disease to infor…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Relationship Between HIV-1 Subtype and ARV Response
A completed clinical trial update investigates whether different HIV-1 subtypes affect response to antiretroviral therapy.
-
CLINICAL_TRIALS withdrawal · 2015-10-01Clinical Trial Update: Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
The observational trial evaluating antiretroviral response in African children using viral load monitoring has been withdrawn. No results ar…
-
FDA approval · 2015-09-30FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
FDA label_change · 2015-09-30FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Ziagen (abacavir sulfate) submitted by ViiV Healthcare Company, resulting in updated labelin…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of an MVA85A prime vaccination followed by BCG boost for tuberculosis in individuals with…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Towards HIV Functional Cure [NA]
A clinical trial investigating strategies toward an HIV functional cure has completed.
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Being Responsible for Ourselves HIV Risk Reduction for Black MSM [NA]
The University of Pennsylvania-sponsored clinical trial 'Being Responsible for Ourselves HIV Risk Reduction for Black MSM' has completed and…
-
FDA approval · 2015-09-28FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for TRIUMEQ (abacavir sulfate, dolutegravir sodium, lamivudine) from ViiV Healthcare Company.
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease [Phase 4]
A Phase 4 clinical trial evaluating rifaximin for liver scarring in HIV-infected individuals with liver disease has been withdrawn.
-
FDA approval · 2015-09-25FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for COMBIVIR (lamivudine and zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) [Phase 3]
Phase 3 trial of Vicriviroc in treatment-experienced HIV patients has completed; the update does not detail results.
-
CLINICAL_TRIALS research · 2015-09-25Clinical Trial Update: Effect of HIV/STD Risk Reduction Program on South African Adolescents [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluates an HIV/STD risk reduction program for South African adolescents.
-
FDA approval · 2015-09-24FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., resulting in changes to its labeling.
-
FDA approval · 2015-09-24FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C., marking an approved regulatory…
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation
This clinical trial update investigates the effects of a dolutegravir-based regimen on the HIV-1 reservoir and immune activation. The study …
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study [Phase 1]
Phase 1 pharmacokinetic study evaluating boosting of Atazanavir 300 mg with either 50 mg or 100 mg ritonavir daily in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
A completed clinical trial named RETRIeVE evaluated a reverse transcriptase inhibitor strategy for HIV infection. The entry notes the study …
-
CLINICAL_TRIALS research · 2015-09-21Clinical Trial Update: Patient Retention in HIV Medical Care in a Primary Care Practice in Australia
This clinical trial update reports on patient retention in HIV medical care within a primary care practice in Australia. The study status is…